Pulike Biological Engineering (603566) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.034x

Based on the latest financial reports, Pulike Biological Engineering (603566) has a cash flow conversion efficiency ratio of 0.034x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥87.38 Million ≈ $12.79 Million USD) by net assets (CN¥2.58 Billion ≈ $377.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Pulike Biological Engineering balance sheet quality to measure how much of total assets are equity-financed.

Pulike Biological Engineering - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how Pulike Biological Engineering's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Pulike Biological Engineering (603566) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Pulike Biological Engineering Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pulike Biological Engineering ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
OPTHEA LTD (SP.ADR/8) F:UKJ2	N/A
Beijing Changjiu Logistics Ltd SHG:603569	-0.013x
Invesco California Value Muni Inc Tr NYSE:VCV	0.018x
Nederman Holding AB ST:NMAN	-0.008x
Guangzhou Hangxin Aviation Technology Co Ltd SHE:300424	0.071x
United Faith Auto-Engineering Co. Ltd. SHE:301112	-0.018x
Kearny Financial Corp NASDAQ:KRNY	0.019x
Regal Investment Fund AU:RF1	0.039x

Annual Cash Flow Conversion Efficiency for Pulike Biological Engineering (2010–2024)

The table below shows the annual cash flow conversion efficiency of Pulike Biological Engineering from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Pulike Biological Engineering.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.63 Billion ≈ $384.28 Million	CN¥268.79 Million ≈ $39.33 Million	0.102x	-1.41%
2023-12-31	CN¥2.72 Billion ≈ $398.59 Million	CN¥282.78 Million ≈ $41.38 Million	0.104x	+27.22%
2022-12-31	CN¥2.80 Billion ≈ $409.51 Million	CN¥228.36 Million ≈ $33.42 Million	0.082x	-30.87%
2021-12-31	CN¥1.80 Billion ≈ $263.46 Million	CN¥212.53 Million ≈ $31.10 Million	0.118x	-22.92%
2020-12-31	CN¥1.71 Billion ≈ $250.17 Million	CN¥261.83 Million ≈ $38.31 Million	0.153x	+81.24%
2019-12-31	CN¥1.66 Billion ≈ $242.62 Million	CN¥140.10 Million ≈ $20.50 Million	0.084x	+9.45%
2018-12-31	CN¥1.64 Billion ≈ $239.34 Million	CN¥126.27 Million ≈ $18.48 Million	0.077x	-14.02%
2017-12-31	CN¥1.57 Billion ≈ $229.57 Million	CN¥140.86 Million ≈ $20.61 Million	0.090x	-47.45%
2016-12-31	CN¥1.48 Billion ≈ $216.71 Million	CN¥253.03 Million ≈ $37.03 Million	0.171x	+22.12%
2015-12-31	CN¥1.34 Billion ≈ $195.68 Million	CN¥187.09 Million ≈ $27.38 Million	0.140x	-36.75%
2014-12-31	CN¥683.59 Million ≈ $100.03 Million	CN¥151.21 Million ≈ $22.13 Million	0.221x	-26.36%
2013-12-31	CN¥603.33 Million ≈ $88.29 Million	CN¥181.21 Million ≈ $26.52 Million	0.300x	-10.59%
2012-12-31	CN¥440.47 Million ≈ $64.45 Million	CN¥147.96 Million ≈ $21.65 Million	0.336x	-31.46%
2011-12-31	CN¥311.26 Million ≈ $45.55 Million	CN¥152.54 Million ≈ $22.32 Million	0.490x	+35.24%
2010-12-31	CN¥195.88 Million ≈ $28.66 Million	CN¥70.98 Million ≈ $10.39 Million	0.362x	--

About Pulike Biological Engineering

SHG:603566 China Biotechnology

Market Cap

$512.98 Million

CN¥3.51 Billion CNY

Market Cap Rank

#12072 Global

#3467 in China

Share Price

CN¥10.13

Change (1 day)

-1.55%

52-Week Range

CN¥9.78 - CN¥15.51

All Time High

CN¥34.10